Nebokitug has received FDA and EMA Orphan Drug and FDA Fast Track designations for the treatment of PSC in adults. About Primary Sclerosing Cholangitis PSC is a rare, debilitating progressive ...

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...

Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...

A commonly used antibiotic called vancomycin, which is usually prescribed to treat infectious diarrhea, may also be helpful ...

potentially the first FDA-approved treatment for primary sclerosing cholangitis (PSC). The company's stock has shown remarkable strength, delivering a 206.4% return over the past year, according ...

Last February, Pliant Therapeutics released 12-week interim data from the 320 mg dose group of INTEGRIS-PSC Phase 2a trial of ...

Moreover, IBD and PSC are closely correlated ... Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

An antibiotic used to treat infective diarrhoea may be an effective drug for a type of inflammatory bowel disease, according to a new study.Researchers from the University of Birmingham, UK, ...

potentially the first FDA-approved treatment for primary sclerosing cholangitis (PSC). The company's stock has shown remarkable strength, delivering a 206.4% return over the past year, according to ...